MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,228,000 | +53.8% | 347,406 | +19.5% | 0.01% | +50.0% |
Q3 2016 | $3,400,000 | +9.7% | 290,805 | +1.3% | 0.00% | 0.0% |
Q2 2016 | $3,099,000 | +41.8% | 286,945 | +21.3% | 0.00% | +33.3% |
Q1 2016 | $2,185,000 | -36.7% | 236,498 | +1.7% | 0.00% | -25.0% |
Q4 2015 | $3,452,000 | -9.0% | 232,591 | +0.6% | 0.00% | -20.0% |
Q3 2015 | $3,793,000 | -28.5% | 231,154 | -0.6% | 0.01% | -28.6% |
Q2 2015 | $5,303,000 | +109.4% | 232,480 | +39.5% | 0.01% | +133.3% |
Q1 2015 | $2,533,000 | +34.2% | 166,656 | +6.3% | 0.00% | +50.0% |
Q4 2014 | $1,887,000 | +5.2% | 156,715 | -0.9% | 0.00% | -33.3% |
Q3 2014 | $1,793,000 | -5.9% | 158,119 | +0.2% | 0.00% | 0.0% |
Q2 2014 | $1,905,000 | +1.1% | 157,738 | -2.5% | 0.00% | 0.0% |
Q1 2014 | $1,884,000 | -33.3% | 161,732 | +1.3% | 0.00% | -25.0% |
Q4 2013 | $2,824,000 | +20.6% | 159,702 | -1.9% | 0.00% | 0.0% |
Q3 2013 | $2,342,000 | -0.3% | 162,763 | +4.4% | 0.00% | 0.0% |
Q2 2013 | $2,348,000 | – | 155,916 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 2,500,000 | $28,350,000 | 2.16% |
SENZAR ASSET MANAGEMENT, LLC | 454,600 | $5,155,000 | 1.51% |
Palo Alto Investors LP | 1,455,176 | $16,502,000 | 1.23% |
SECTORAL ASSET MANAGEMENT INC | 2,134,440 | $24,205,000 | 1.02% |
AlphaMark Advisors, LLC | 130,699 | $1,482,000 | 0.94% |
Cheyne Capital Management (UK) LLP | 172,353 | $1,955,000 | 0.70% |
Regal Investment Advisors LLC | 183,972 | $2,086,000 | 0.63% |
Tekla Capital Management LLC | 1,067,575 | $12,106,000 | 0.57% |
March Altus Capital Management LP | 103,729 | $1,176,000 | 0.47% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 19,500 | $221,000 | 0.33% |